About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,781 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,781 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 441-460 of 4,781 trials

RecruitingNeoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary CancerAdjuvant chemotherapy after surgery significantly improved the survival of pancreatic cancer (PC) patients, but there is a problem that only about 50% of patients start adjuvant…NCT07081360·Minya, Minya Governorate Not yet recruitingPhase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V MutationThis is a single-arm, multicenter, open-label, Phase 1a/1b dose-escalation and dose-expansion study designed to evaluate the safety, preliminary antitumor activity, and…NCT07875920·Beijing, Beijing Municipality and 1 other

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

CompletedAnalgesia and Pancreatic Cancer SurgeryLong-term survival for patients with pancreatic carcinoma is low, even following resection, the 5-year survival rate of patients ranges from 10 to 25%1.NCT01929915·Taipei

TerminatedTrial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the PancreasThe purpose of this study is to assess the 6-month survival rate and safety of talabostat and gemcitabine in patients with stage IV adenocarcinoma of the pancreas.NCT00116389·Florence, Alabama and 27 others

RecruitingComparing Laparoscopic and Open Surgery for Pancreatic CarcinomaBackground: Pancreatic cancer (PC) is one of the most aggressive malignant neoplasms with poor outcomes. Pancreatoduodenectomy (PD) is the only curative treatment for PC.NCT03785743·Wuhan, Hubei

UnknownSelf-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary ObstructionA randomised clinical trial to compare the clinical efficacy of multiple plastic stents to fully covered self expanding metal stents in the palliation of distal malignant biliary…NCT03821025·Cape Town, Western Cape

TerminatedStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsThis study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene…NCT04383210·Birmingham, Alabama and 41 others

RecruitingTissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft PancreasThis is a single-center, randomized controlled trial comparing the efficacy of pancreaticojejunostomy with modified N-butyl-2-cyanoacrylate(Glubran® 2) versus standard…NCT07155525·Minya, Minya Governorate

CompletedSurvivorship Promotion In Reducing IGF-1 TrialThis is a prospective, single-center randomized trial with three arms, and an allocation ratio of 1:1:1.NCT02431676·Baltimore, Maryland

RecruitingStudy-group on Palliative ERCP And RFA-ablation in Metastatic and Inoperable Pancreatic TumorsPancreatic ductal adenocarcinoma (PDAC) is a very aggressive cancer and may become the second leading cause of cancer death by 2030.NCT07191418·Umeå

CompletedProspective Study FNB, Is It Time To Abandon Cytological AssessmentEndoscopic Ultrasound (EUS) is a minimally invasive procedure used by gastroenterologists to examine pancreatic masses and lesions.NCT04165018·Houston, Texas and 1 other

RecruitingEUS Examination Using EndoSound Vision System vs. Standard EchoendoscopeThis is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.NCT06340620·Orlando, Florida

CompletedRandomized Controlled Trial of Gemcitabine Combined With 125I BrachytherapyFor patients with unresectable locally advanced pancreatic cancer, the combined use of external-beam radiation therapy (EBRT) and systemic chemotherapy of 5-FU has been widely…NCT00644618

CompletedOxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerRATIONALE: Drugs used in chemotherapy, such as oxaliplatin and gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping…NCT00266097·Chapel Hill, North Carolina

CompletedOpen-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal CancerThis is a clinical research study of an investigational (FDA BB-IND 10091) treatment for patients with pancreatic cancer (all stages) and advanced colorectal cancer that no longer…NCT01053013·New York, New York

CompletedLow Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)The purposes of this study are: 1.NCT00390182·Baltimore, Maryland and 1 other

CompletedOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenRATIONALE: Antiemetic drugs may help to reduce or prevent vomiting in patients treated with radiation therapy.NCT00016380·Edmonton, Alberta and 13 others

CompletedCombining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic CancerPancreatic cancer is an aggressive, largely chemo-resistant disease with a poor prognosis.NCT00260364·London and Surrey, London

Not yet recruitingPredictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic ductal adenocarcinoma (PDAC) is one of the cancers with the poorest prognosis and is often diagnosed at an advanced stage, resulting in very low 5-year survival rates.NCT07709052

CompletedSafety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the PancreasThe purpose of this trial is to determine the maximum tolerated dose and the dose-limiting toxicity of biweekly oxaliplatin in combination with fixed doses of irinotecan…NCT00220649·New York, New York

PreviousPage 23 of 240Next